-transparent.png){kind=logo}
We reported here an adult patient with vanishing bile duct syndrome due to chronic EBV infection. A 22-year-old male was admitted to a nearby hospital complaining of a sore throat and jaundice. He received a high dose of prednisolone for bile stasis of acute viral hepatitis. However, the hepatitis did not improve, and he was transferred to our hospital. He had exhibited jaundice for one year as well as hemophagocytic syndrome and intestinal perforation. Subtotal intestinal resection was successfully performed. Three follow-up biopsied liver specimens indicated vanishing bile duct syndrome. Positive results of EBV-DNA in his serum and mRNA of EBV by in situ hybridization of his liver indicated that massive doses of prednisolone caused chronic EBV infection and vanishing bile duct syndrome.
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
May 2022,
ACG case reports journal,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
January 2010,
Journal of clinical gastroenterology,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
July 2010,
Journal of child neurology,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
July 1992,
The British journal of surgery,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
January 1995,
Ryoikibetsu shokogun shirizu,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
February 2008,
Clinics in liver disease,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
August 1996,
The American journal of gastroenterology,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
August 2012,
World journal of gastrointestinal endoscopy,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
January 2022,
Cureus,
K Kikuchi, and
H Miyakawa, and
K Abe, and
H Fujikawa, and
T Horiuchi, and
K Nagai, and
M Kako
April 2020,
Clinical and experimental dermatology,
